greeksoup/ stock research
Stock research / United States / Funds / Sivik Global Healthcare LLC

Sivik Global Healthcare LLC

CIK 1596452 · latest 13F filed 13 October 2026 · Read the filing on EDGAR

Sivik Global Healthcare LLC reported 35 US-listed holdings worth $175.0 million in its 13F for the quarter ended 30 September 2026, filed 13 October 2026. Its largest: SPDR Ser Trust (16.2%), Humana Inc. (3.9%) and Johnson & Johnson (3.6%). Against the quarter before, it opened 12 positions, added to 14, trimmed 5 and sold out of 11.

Reported holdings$175.0M+32.9% on Q2 2026
Positions35+1 on Q2 2026
The largest ten46.2%of its reported holdings
Latest 13FQ3 2026filed 13 October 2026
Where the money is
Added toHeldTrimmed
XBI16.2%HUM3.9%JNJ3.6%MRK3.3%ABBV3.3%TMO3.3%CAH3.2%MCK3.2%DHR3.2%UNH3.1%VRTX3.1%ELV3.1%ABT3.1%COR3.1%21 more41.3%

The 14 largest of its 35 positions, each sized by its share of the reported holdings, coloured by the change in shares against Q2 2026.

Reported holdings, quarter by quarter
Q3 2024: $234.6 million in 33 positions$235MQ3 24Q4 2024: $180.8 million in 36 positions$181MQ4 24Q1 2025: $182.9 million in 29 positions$183MQ1 25Q2 2025: $223.6 million in 38 positions$224MQ2 25Q3 2025: $190.5 million in 35 positions$190MQ3 25Q4 2025: $204.8 million in 41 positions$205MQ4 25Q1 2026: $131.7 million in 34 positions$132MQ1 26Q2 2026: $131.7 million in 34 positions$132MQ2 26Q3 2026: $175.0 million in 35 positions$175MQ3 26

What the fund reported holding at each quarter's end; hover a bar for the number of positions

What its reported holdings returned

Held through each quarter, the holdings it reported returned +12.5% over the 8 quarters to 30 September 2026, against +32.9% for the S&P 500.

Its reported holdingsThe S&P 500
90105120135Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Its holdings +12.5%S&P 500 +32.9%

Not the fund's own return: each 13F's holdings are kept unchanged until the next one, so trades inside a quarter, dividends, cash and fees are left out. A rough guide to how its picks have done over time.

What it did on the quarter

Opened 12Added 14Held 4Trimmed 5Sold out 11
Opened: 12Added: 14Held: 4Trimmed: 5Sold out: 11

Its positions against its 13F for the quarter to 30 June 2026; a change under 0.1% of a position counts as held

Opened 12

  1. Centene Corp. CNC$5.0 million
  2. Revvity, Inc. RVTY$4.6 million
  3. Bruker Corp. BRKR$4.2 million
  4. Medtronic plc MDT$3.9 million
  5. Repligen Corp. RGEN$3.8 million
  6. Cigna Group CI$3.6 million
  7. Avantor, Inc. AVTR$2.6 million
  8. BioNTech SE BNTX$2.2 million

and 4 more in the table below

Added to 14

  1. SPDR Ser Trust XBI+30,000 shares · +20%
  2. Elevance Health, Inc. ELV+9,000 shares · +180%
  3. Encompass Health Corp. EHC+25,000 shares · +167%
  4. Abbott Laboratories ABT+30,000 shares · +120%
  5. Edwards Lifesciences Corp. EW+25,000 shares · +125%
  6. McKesson Corp. MCK+2,500 shares · +62%
  7. UnitedHealth Group Inc. UNH+5,000 shares · +50%
  8. AbbVie Inc. ABBV+7,000 shares · +47%

and 6 more in the table below

Trimmed 5

  1. Waters Corp. WAT-5,000 shares · -33%
  2. Eli Lilly & Co. LLY-770 shares · -15%
  3. Humana Inc. HUM-2,300 shares · -12%
  4. Bio-Rad Laboratories, Inc. BIO-2,000 shares · -20%
  5. Mettler Toledo International Inc. MTD-250 shares · -9%

Sold out of 11

  1. Call- BSX 100 @ 75 Exp 04/17/2026$5.0 million last quarter
  2. Intuitive Surgical Inc. ISRG$4.1 million last quarter
  3. AstraZeneca PLC AZN$3.9 million last quarter
  4. Boston Scientific Corp. BSX$3.9 million last quarter
  5. Tenet Healthcare Corp. THC$3.8 million last quarter
  6. Stryker Corp. SYK$3.3 million last quarter
  7. Universal Health Services Inc. UHS$3.1 million last quarter
  8. Regeneron Pharmaceuticals, Inc. REGN$3.1 million last quarter

What it holds

CompanySharesValueOf its bookChange in shares
SPDR Ser Trust XBI180.0K$28.4 million16.21%+30.0K
Humana Inc. HUM17.7K$6.8 million3.86%-2.3K
Johnson & Johnson JNJ24.0K$6.4 million3.63%+4.0K
Merck & Co., Inc. MRK40.0K$5.8 million3.32%no change
AbbVie Inc. ABBV22.0K$5.8 million3.29%+7.0K
Thermo Fisher Scientific Inc. TMO8.5K$5.7 million3.28%+500
Cardinal Health Inc. CAH25.0K$5.6 million3.18%+1.0K
McKesson Corp. MCK6.5K$5.5 million3.17%+2.5K
Danaher Corp. DHR25.0K$5.5 million3.16%+5.0K
UnitedHealth Group Inc. UNH15.0K$5.5 million3.15%+5.0K
Vertex Pharmaceuticals Inc. VRTX10.5K$5.5 million3.14%+500
Elevance Health, Inc. ELV14.0K$5.4 million3.11%+9.0K
Abbott Laboratories ABT55.0K$5.4 million3.11%+30.0K
Cencora, Inc. COR18.0K$5.4 million3.09%+3.0K
Agilent Technologies, Inc. A30.0K$5.2 million2.95%no change
Centene Corp. CNC80.0K$5.0 million2.84%new
Eli Lilly & Co. LLY4.2K$4.9 million2.80%-770
Encompass Health Corp. EHC40.0K$4.9 million2.78%+25.0K
Revvity, Inc. RVTY30.0K$4.6 million2.62%new
Waters Corp. WAT10.0K$4.4 million2.51%-5.0K
Bruker Corp. BRKR65.0K$4.2 million2.40%new
Edwards Lifesciences Corp. EW45.0K$3.9 million2.22%+25.0K
Medtronic plc MDT45.0K$3.9 million2.22%new
Repligen Corp. RGEN20.0K$3.8 million2.20%new
Mettler Toledo International Inc. MTD2.5K$3.8 million2.16%-250
Gilead Sciences, Inc. GILD25.0K$3.7 million2.13%no change
Cigna Group CI13.2K$3.6 million2.05%new
Biogen Inc. BIIB15.0K$3.4 million1.94%no change
Bio-Rad Laboratories, Inc. BIO8.0K$3.0 million1.73%-2.0K
Avantor, Inc. AVTR175.0K$2.6 million1.50%new
BioNTech SE BNTX22.0K$2.2 million1.24%new
Moderna, Inc. MRNA10.0K$1.9 million1.10%new
argenx SE ARGX2.0K$1.9 million1.10%new
Madrigal Pharmaceuticals Inc. MDGL2.5K$1.3 million0.72%new
Twist Bioscience Corp. TWST1.1K$217,9750.12%new
Every US-listed position in the fund's 13F for the quarter ended 30 September 2026, by the value it reported.
Read moreChange is shares against its 13F for the quarter before; the 11 it sold out of are in the box above.